Advance Search | Bentham Science

Anticancer Metallotherapeutics in Preclinical Development

Journal: Current Medicinal Chemistry
Volume: 18 Issue: 3 Year: 2011 Page: 4738-4752
Author(s): G. N. Kaluderovic, R. Paschke

Critical Questions for Preclinical Trials on Safety and Efficacy of Vascular Endothelial Growth Factor-Based Therapeutic Angiogenesis for Ischemic Stroke

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10 Issue: 2 Year: 2011 Page: 215-234
Author(s): P. S. Manoonkitiwongsa

A Review of Preclinical Research Demonstrating that Drug and Non-Drug ReinforcersDifferentially Affect Behavior

Journal: Current Drug Abuse Reviews
Volume: 4 Issue: 4 Year: 2011 Page: 261-269
Author(s): David N. Kearns, Maria A. Gomez-Serrano, Brendan J. Tunstall

Disulfiram, and Disulfiram Derivatives as Novel Potential Anticancer Drugs Targeting the Ubiquitin Proteasome System in Both Preclinical and Clinical Studies

Journal: Current Cancer Drug Targets
Volume: 11 Issue: 3 Year: 2011 Page: 338-346
Author(s): F. R. Kona, D. Buac, A. M. Burger

Therapeutic Targeting of TRPV1 by Resiniferatoxin, from Preclinical Studies to Clinical Trials

Journal: Current Topics in Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2011 Page: 2159-2170
Author(s): Igor Kissin, Arpad Szallasi

Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials

Journal: Current Cancer Drug Targets
Volume: 11 Issue: 3 Year: 2011 Page: 254-284
Author(s): B. C. Potts, M. X. Albitar, K. C. Anderson, S. Baritaki, C. Berkers, B. Bonavida, J. Chandra, D. Chauhan, J. C. Cusack, W. Fenical, I. M. Ghobrial, M. Groll, P. R. Jensen, K. S. Lam, G. K. Lloyd, W. McBride, D. J. McConkey, C. P. Miller, S. T.C. Neuteboom, Y. Oki, H. Ovaa, F. Pajonk, P. G. Richardson, A. M. Roccaro, C. M. Sloss, M. A. Spear, E. Valashi, A. Younes, M. A. Palladino

Preclinical Assessment of Drug Combinations for the Treatment of Pain: Isobolographic and Dose-Addition Analysis of the Opioidergic System

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10 Issue: 5 Year: 2011 Page: 529-535
Author(s): Bradford D. Fischer

EZN-2208 (PEG-SN38), A 40 kDa Polyethylene Glycol (PEG) Conjugate, As an Anticancer Agent: Review of Preclinical and Clinical Data

Journal: Current Bioactive Compounds
Volume: 7 Issue: 1 Year: 2011 Page: 3-7
Author(s): Hong Zhao

Targeted Alpha Therapy with 213Bi

Journal: Current Radiopharmaceuticals
Volume: 4 Issue: 4 Year: 2011 Page: 295-305
Author(s): Alfred Morgenstern, Frank Bruchertseifer, Christos Apostolidis

INNO-206 (DOXO-EMCH), an Albumin-Binding Prodrug of Doxorubicin Under Development for Phase II Studies

Journal: Current Bioactive Compounds
Volume: 7 Issue: 1 Year: 2011 Page: 33-38
Author(s): F. Kratz

Search

Find Journals, Volumes, Issues, Articles, Ebooks and Chapters

Search Result "preclinical study"